- CEO
- Yoon-Min Park
- Full Time Employees
- 92
- Sector
- Electronic technology
- Industry
- Semiconductors
- Address
- Yongin-si South Korea
- IPO Date
- Aug 8, 2006
- Business
- Lumens Bios Co., Ltd. is a South Korea-based optical semiconductor and biotechnology company primarily engaged in the research, development, manufacture, and commercialization of advanced light-emitting diode (LED) packages, optical display modules, micro-LED displays, and bio-photonic solutions. Founded in 1996 and headquartered in Yongin-si, Gyeonggi-do, South Korea, the company operates across display components, automotive electronics, specialty illumination, and life sciences business segments, supplying original equipment manufacturers (OEMs), electronic manufacturing services (EMS) providers, automotive Tier-1 suppliers, and commercial enterprises across South Korea, Greater China, Southeast Asia, North America, and Europe.
The company's primary products and services are structured into comprehensive technology categories: display LED solutions, including LED backlight units (BLUs) and light bars for ultra-high-definition (UHD) televisions, desktop monitors, notebook computers, and tablet devices; next-generation micro-LED and mini-LED modules, featuring fine-pitch micro-LED panels for commercial digital signage, smart glass optical engines, augmented reality (AR) micro-displays, and automotive head-up display (HUD) units; automotive lighting systems, encompassing exterior forward lighting, daytime running lights (DRLs), rear combination lamps (RCLs), turn indicators, center high-mounted stop lamps (CHMSLs), and interior ambient mood lighting; specialty and general lighting, comprising high-efficiency commercial and industrial luminaire modules, street lamps, architectural floodlights, and ultraviolet (UV-A, UV-C) LED systems designed for surface sterilization, water purification, and industrial curing applications; and bio-photonic healthcare solutions, which provide optical biosensors, optical diagnostic devices, phototherapeutic wellness instruments, and biomedical illumination modules.
In recent developments, the company executed a strategic corporate reorganization and name change to Lumens Bios Co., Ltd., marking a major strategic transition from legacy consumer display backlight components toward high-value bio-photonics, medical technologies, and advanced micro-display applications. In alignment with this strategic transformation, the company restructured its production footprint by rationalizing lower-margin standard LED manufacturing lines and reallocating capital resources toward micro-LED cleanroom capacity and biosensor R&D facilities. Additionally, the company has forged strategic technological partnerships and joint development initiatives with life science institutions and mobility component manufacturers to accelerate the commercialization of point-of-care optical diagnostics and automotive smart surface displays, supported by capital management initiatives to enhance operational liquidity and fund ongoing product diversification.